| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/29/2004 | WO2004009775A2 Methods and compositions relating to chimeric nicotinic receptor subunits |
| 01/29/2004 | WO2004009769A2 COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF ANGIOGENESIS |
| 01/29/2004 | WO2004009768A2 Viral vectors containing recombination sites |
| 01/29/2004 | WO2004009763A2 Use of vaccinia virus deleted for the e3l gene as a vaccine vector |
| 01/29/2004 | WO2004009762A2 Flea and tick octopamine receptor nucleic acid molecules, proteins and thereof |
| 01/29/2004 | WO2004009761A2 Methods for using artificial polynucleotides and compositions thereof to reduce transgene silencing |
| 01/29/2004 | WO2004009759A2 Novel proteins in enteroaggregative escherichia coli (eaec) useful for diagnosis and therapy of eaec infections |
| 01/29/2004 | WO2004009631A2 Human gnrh (type 2) receptor |
| 01/29/2004 | WO2004009630A1 Regulation of human serotonin receptor |
| 01/29/2004 | WO2004009627A1 Pegylated erythropoietic compounds |
| 01/29/2004 | WO2004009626A1 Novel gene associated with rheumatoid arthritis |
| 01/29/2004 | WO2004009624A2 Three finger toxin fold protein |
| 01/29/2004 | WO2004009621A2 Polypeptides of nontypeable haemophilus influenzae |
| 01/29/2004 | WO2004009619A2 Protein complexes of the tip60 transcriptional activator protein |
| 01/29/2004 | WO2004009618A2 Recombinant production of mixtures of antibodies |
| 01/29/2004 | WO2004009617A1 NOVEL Notch-ORIGIN POLYPEPTIDES AND BIOMARKERS AND REAGENTS USING THE SAME |
| 01/29/2004 | WO2004009615A2 Cd40-ligand lacking native-pattern glycosylation |
| 01/29/2004 | WO2004009541A2 Antisense modulation of endothelial lipase expression |
| 01/29/2004 | WO2004009239A1 Slip cover for heated platen assembly |
| 01/29/2004 | WO2004009133A1 Adenoviral vector incorporating zipper peptide-modified fiber protein and uses thereof |
| 01/29/2004 | WO2004009099A1 Phosphorylated dextran |
| 01/29/2004 | WO2004009098A1 Antisense compounds, methods and compositions for treating mmp-12 related inflammatory disorders |
| 01/29/2004 | WO2004009032A2 Method and composition for treating and preventing hepatitis b infection and symptoms thereof |
| 01/29/2004 | WO2004009024A2 Modulation of protein kinase c-iota expression |
| 01/29/2004 | WO2004009022A2 Method for augmenting vision in persons suffering from photoreceptor cell degeneration |
| 01/29/2004 | WO2004009021A2 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 01/29/2004 | WO2004009018A2 Antisense modulation of ptprm expression |
| 01/29/2004 | WO2003090664A3 Mutated hpv-16 e7 polypeptide, pharmaceutical composition comprising it and its preparation process |
| 01/29/2004 | WO2003087357A3 Nucleic acid comprising retinal-specific regulatory region |
| 01/29/2004 | WO2003085098A3 Identification of virulence associated regions rd1 and rd5 enabling the development of improved vaccines of m. bovis bcg and m. microti |
| 01/29/2004 | WO2003080654B1 Helicobacter flagellar, motility polypeptides |
| 01/29/2004 | WO2003078640A8 Recombinant drug-sensitive vaccinia virus as smallpox vaccine |
| 01/29/2004 | WO2003074554A3 Apoptogenic-bacteriocins combining broad spectrum antibiotic and selective anti-tumoral activities, and compositions and uses thereof |
| 01/29/2004 | WO2003070887A3 RNA INTERFERENCE MEDIATED INHIBITION OF POLYCOMB GROUP PROTEIN EZH2 GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 01/29/2004 | WO2003070878A3 Antisense modulation of hematopoietic cell protein tyrosine kinase expression |
| 01/29/2004 | WO2003069978A3 Methods for altering organ mass in plants |
| 01/29/2004 | WO2003059932A3 Methods of inducing or enhancing connective tissue repair |
| 01/29/2004 | WO2003054207A3 Fermentation process for the preparation of l-amino acids using coryneform bacteria |
| 01/29/2004 | WO2003052099A3 Methods of parallel gene cloning and analysis |
| 01/29/2004 | WO2003050546A3 Resistance circuit stabilization and pulse duration control systems for electroporation instruments |
| 01/29/2004 | WO2003048775A3 Peptides and method for detecting alzheimer's disease and differentiating alzheimer's disease from other demential diseases |
| 01/29/2004 | WO2003048184A3 Flavivirus ns1 subunit vaccine |
| 01/29/2004 | WO2003047634A3 Nucleic acids and methods for treating ebv-positive cancers |
| 01/29/2004 | WO2003047631A3 Clasp-pna-conjugate for the specific transport of nucleic acids which are thermally active |
| 01/29/2004 | WO2003046209A3 Method and biosensor for detecting macromolecular biopolymers |
| 01/29/2004 | WO2003044186A3 Novel gene cluster of pederin biosynthesis genes |
| 01/29/2004 | WO2003039471A3 Catalytic antibodies raised against sarin and process for the preparation thereof |
| 01/29/2004 | WO2003038113A3 Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 25943 |
| 01/29/2004 | WO2003037074A3 Methods of generating knock-out rodents |
| 01/29/2004 | WO2003033708A3 Regulation of human serine/threonine protein kinase |
| 01/29/2004 | WO2003025141A3 Genetic analysis for stratification of cancer risk |
| 01/29/2004 | WO2003020878A3 Amplification and detection reagents for hiv-1 |
| 01/29/2004 | WO2003018766A3 Self-processing plants and plant parts |
| 01/29/2004 | WO2003017944A3 Gpi-anchored cytokines |
| 01/29/2004 | WO2003016537A3 Method for repairing a mutant rna from a dna with genetic defects and for the programmed death of tumour cells by rna trans-splicing as well as a method for identifying naturally trans-spliced cellular rna |
| 01/29/2004 | WO2003008545A3 Antisense modulation of glioma-associated oncogene-2 expression |
| 01/29/2004 | WO2003008451A3 Modification of human variable domains |
| 01/29/2004 | WO2003004662A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family |
| 01/29/2004 | WO2003004606A3 Antisense oligonucleotides and related methods for regulating cell death |
| 01/29/2004 | WO2003002137A3 Trp1, mct, or ftz-f1 homologous proteins involved in the regulation of energy homeostasis |
| 01/29/2004 | WO2002099060A3 Dgks as modifiers of the p53 pathway and methods of use |
| 01/29/2004 | WO2002088377A3 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 01/29/2004 | WO2002086134B1 Buffer solution for electroporation and a method comprising the use of the same |
| 01/29/2004 | WO2002083900A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 01/29/2004 | WO2002078631A3 Improved conditionally replicating vectors for inhibiting viral infections |
| 01/29/2004 | WO2002072794A3 Immunoglobulin superfamily proteins |
| 01/29/2004 | WO2002070737A3 Compositions and methods relating to osteoarthritis |
| 01/29/2004 | WO2002068698A3 Use of nucleic acid libraries to create toxicological profiles |
| 01/29/2004 | WO2002068652A3 Nov-x proteins and nucleic acids encoding same |
| 01/29/2004 | WO2002066615A9 Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 01/29/2004 | WO2002059287A3 Novel human kinases and polynucleotides encoding the same |
| 01/29/2004 | WO2002058459A9 Transgenic trees having increased resistance to imidazolinone herbicides |
| 01/29/2004 | WO2001005936A3 Transformation method and transgenic plants produced thereby |
| 01/29/2004 | WO2000063417A8 Proteins that regulate systemic acquired resistance in plants |
| 01/29/2004 | US20040019935 Gene of aluminum-activated malate transporter of a plant and a protein encoded by the gene |
| 01/29/2004 | US20040019934 Root-specific conifer gene promoter and its use |
| 01/29/2004 | US20040019933 An isolated polynucleotide encoding a PtM3 or its homolog PtM4 polypeptide; producing a transgenic plant that exhibits altered characteristics resulting from over expression or under expression of above polypeptide |
| 01/29/2004 | US20040019932 Plant raffinose saccharide biosynthetic enzymes |
| 01/29/2004 | US20040019931 Introducing into a plant nucleotide sequences encoding enzymes that alter pyruvate synthesis. |
| 01/29/2004 | US20040019930 A plant is infected at one or more locations with a recombinant viral vector, which is both an initiator and a target of the RNA-triggered gene silencing in the plant, and the vector upon infection directs self-replication |
| 01/29/2004 | US20040019929 Aromatic amino acid biosynthetic enzymes |
| 01/29/2004 | US20040019928 Nucleic acids that encode reverse transcriptases |
| 01/29/2004 | US20040019927 Polynucleotides and polypeptides in plants |
| 01/29/2004 | US20040019926 Novel plant cyclin-dependent kinase inhibitors |
| 01/29/2004 | US20040019925 Biochemistry-related polynucleotides and polypeptides in plants |
| 01/29/2004 | US20040019924 Nuclear transfer embryo formation method |
| 01/29/2004 | US20040019923 A vector containing a coding sequence and a promoter to express such sequence in an avian oviduct, and the sequence is either recombinant transgenic poultry derived interferon-alpha 2b or erythropoietin coding sequence |
| 01/29/2004 | US20040019922 Exogenous proteins expressed in avians and their eggs |
| 01/29/2004 | US20040019921 Non-human mammal with disrupted or modified MIF gene, and uses thereof |
| 01/29/2004 | US20040019920 Transgenic animals |
| 01/29/2004 | US20040019919 Calsyntenin-1-3 proteins, predominantly expressed in the nervous system , useful for the screening and for the preparation of a medicament for the treatment of nervous system disorders, most preferably brain |
| 01/29/2004 | US20040019916 In vivo homologous sequence targeting in eukaryotic cells |
| 01/29/2004 | US20040019196 Compositions and methods for using a solid support to purify RNA |
| 01/29/2004 | US20040019195 Foreign nucleic acid molecule encoding multiple costimulatory molecules, such as B7-1 or B7-2 (antigents), intercellular adhesion molecules and leukocyte function associated antigen-3 |
| 01/29/2004 | US20040019192 Process for modifying plants |
| 01/29/2004 | US20040019188 Targeting through integrins |
| 01/29/2004 | US20040019186 Complex of lecithin and sugar; immobilization; washing; liquid removal; recovering |
| 01/29/2004 | US20040019181 Antimicrobial cationic peptides |
| 01/29/2004 | US20040019103 Method of enhancing cellular production of molecular chaperon, hydroxylamine derivatives useful for enhancing the chaperon production and the preparation thereof |
| 01/29/2004 | US20040019009 A compound 8 to 50 nucleobases in length targeted to a nucleic acid molecule, specifically hybridizes with such nucleic acid, encoding IL-1 receptor-associated kinase-4; useful for treating cancer, infection and inflammation |